2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action.

Autor: Campbell NRC; Special Advisor to the board, and Past president (ex officio), World Hypertension League, Hong Kong, China. ncampbel@ucalgary.ca.; Department of Medicine, University of Calgary, Calgary, AB, Canada. ncampbel@ucalgary.ca., Whelton PK; President-Elect, World Hypertension League, Hong Kong, China.; Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA., Orias M; Vice President, World Hypertension League, Hong Kong, China.; Yale University, New Haven, CT, USA.; Sanatorio Allende, Córdoba, Argentina., Wainford RD; Chair, International Society of Hypertension, Membership Committee, International Society of Hypertension, Colchester, UK.; Department of Pharmacology and Experimental Therapeutics and the Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA, USA., Cappuccio FP; Past President, British and Irish Hypertension Society, Edinburgh, UK.; University of Warwick, WHO Collaborating Centre for Nutrition, Warwick Medical School, Coventry, UK., Ide N; Resolve to Save Lives, an Initiative of Vital Strategies, New York, NY, USA., Neal B; WHO Collaborating Centre on Population Salt Reduction, Sydney, NSW, Australia.; The George Institute for Global Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, Paddington, London, UK.; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia., Cohn J; Resolve to Save Lives, an Initiative of Vital Strategies, New York, NY, USA., Cobb LK; Resolve to Save Lives, an Initiative of Vital Strategies, New York, NY, USA., Webster J; WHO Collaborating Centre on Population Salt Reduction, Sydney, NSW, Australia.; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia., Trieu K; WHO Collaborating Centre on Population Salt Reduction, Sydney, NSW, Australia.; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia., He FJ; Wolfson Institute of Population Health, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK., McLean RM; Department of Preventive & Social Medicine, University of Otago, Dunedin, New Zealand., Blanco-Metzler A; Costa Rican Institute of Research and Teaching in Nutrition and Health (INCIENSA), Tres Rios, Costa Rica., Woodward M; WHO Collaborating Centre on Population Salt Reduction, Sydney, NSW, Australia.; The George Institute for Global Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, Paddington, London, UK.; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia., Khan N; Officer at Large, International Society of Hypertension, Chair International Society of Hypertension Research and Education Committee, International Society of Hypertension, Colchester, UK.; Center for Health Evaluation and Outcomes Sciences, University of British Columbia, Vancouver, BC, Canada., Kokubo Y; International Society of Hypertension Education Lead, Colchester, UK.; Department of Preventive Cardiology, National Cerebral and Cardiovascular Center, Osaka, Japan., Nederveen L; Advisor Food, Nutrition and Physical Activity in Schools, Pan American Health Organization, Washington DC, MD, USA., Arcand J; Faculty of Health Sciences, Ontario Tech University, Oshawa, ON, Canada., MacGregor GA; Chair, Action on Salt, London, UK.; Chair, Action on Sugar, London, UK.; Chair, World Action on Salt Sugar and Health (WASSH), London, UK.; Chair Blood Pressure UK, London, UK.; Wolfson Institute of Population Health, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK., Owolabi MO; Board member, Director (Sub-Saharan Africa), World Hypertension League, Hong Kong, China.; Dean, Faculty of Clinical Sciences, Director Center for Genomic and Precision Medicine, College of Medicine,  University of Ibadan, Ibadan, Nigeria.; World Stroke Organization Geneva, Geneva, Switzerland.; Lead Co-Chair Lancet Commission on Stroke, London, UK., Lisheng L; Past President (ex officio), World Hypertension League, Hong Kong, China., Parati G; Secretary-General, World Hypertension League, Hong Kong, China.; Italian Society of Arterial Hypertension, Milan, Italy.; Department of Medicine and Surgery, University of Milano-Bicocca and IRCCS, Istituto Auxologico Italiano, Milan, Italy., Lackland DT; Past President, World Hypertension League, Hong Kong, China.; Division of Translational Neurosciences and Population Studies, Department of Neurology, Medical University of South Carolina, Charleston, SC, USA., Charchar FJ; Treasurer, International Society of Hypertension, Colchester, UK.; Health Innovation and Transformation Centre, Federation University Australia, Ballarat, VIC, Australia.; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.; Department of Anatomy and Physiology, University of Melbourne, Parkville, VIC, Australia., Williams B; Secretary, International Society of Hypertension, Colchester, UK.; University College London, NIHR University College London, Hospitals Biomedical Research Centre, London, UK., Tomaszewski M; President, International Society of Hypertension, Colchester, UK.; Division of Cardiovascular Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK.; Manchester Heart Centre and Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK., Romero CA; Chair, International Society of Hypertension Regional Advisory Group - Americas Colchester, Colchester, UK.; Department of Internal Medicine, Emory University, Atlanta, Georgia., Champagne B; Director, Coalición Latinoamérica Saludable (CLAS), McKinney, TX, USA., L'Abbe MR; Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Director, WHO Collaborating Centre on Nutrition Policy for Chronic Disease Prevention, Toronto, ON, Canada., Weber MA; Advisor, Executive Committee, World Hypertension League, Hong Kong, China.; Professor of Medicine, Division of Cardiovascular Disease, State University of New York, Downstate Medical Center, New York, NY, USA., Schlaich MP; President, High Blood Pressure Research Council of Australia, Tuggerah, NSW, Australia.; Dobney Hypertension Centre, Medical School - Royal Perth Hospital Unit, Royal Perth Hospital Research Foundation, The University of Western Australia, Perth, WA, Australia., Fogo A; President, International Society of Nephrology, Brussels, Belgium.; Professor of Pathology, Microbiology and Immunology, Professor of Medicine, John L. Shapiro Chair of Pathology, Professor of Pediatrics, Vanderbilt University, Nashville, TN, USA., Feigin VL; Co-Chair Global Policy Committee, member of the Executive Committee, World Stroke Organization, Geneva, Switzerland.; Director of National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand., Akinyemi R; Founding Chair, Steering Committee, African Stroke Organization, Ibadan, Nigeria.; Institute for Advanced Medical Research and Training and Center for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria., Inserra F; Past President, Argentine Society of Arterial Hypertension, Buenos Aires, Argentina.; Advisor to the Academic Vice-Chancellor, Maimonides University, Buenos Aires, Argentina., Menon B; Founder and Secretary, Dr Bindu Menon Foundation (India), Nellore, India., Simas M; Nutritionist, Brazilian Society of Hypertension, Sao Paulo, Brazil., Neves MF; Past President, Brazilian Society of Hypertension, Sao Paulo, Brazil.; Full Professor of Internal Medicine and Director of the Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro, Brazil., Hristova K; Board member, Director - Eastern European Regional Office, World Hypertension League, Hong Kong, China.; Member, Research and Education Committee, International Society of Hypertension, Colchester, UK.; Bulgarian League of Hypertension, President of Bulgarian Society of Cardiovascular Imaging, Sofia, Bulgaria.; Sofia University, Faculty of Medicine, Center of Cardiovascular diseases, Sofia, Bulgaria., Pullen C; Chief Executive Officer, Canadian Cardiovascular Society, Ottawa, ON, Canada., Pandeya S; President, Canadian Society of Nephrology, Montreal, QC, Canada., Ge J; President, Cardiology Branch, Chinese Medical Doctors Association, Beijing, China., Jalil JE; President, Chilean Society of Hypertension, Santiago, Chile.; Advanced Center for Chronic Diseases (ACCDiS), Division de Enfermedades Cardiovasculares, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile., Wang JG; President, Chinese Hypertension League, Beijing, China.; The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Wideimsky J; President, Czech Society of Hypertension, Prague, Czech Republic., Kreutz R; President, European Society of Hypertension, Zug, Switzerland.; Charité - Universitätsmedizin Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany., Wenzel U; Chairman of the Board, German Society of Hypertension, Heidelberg, Germany., Stowasser M; Past President, Treasurer, High Blood Pressure Research Council of Australia, Tuggerah, NSW, Australia., Arango M; Director, Policy and Advocacy, Heart and Stroke Foundation of Canada, Ottawa, ON, Canada., Protogerou A; Board member, Hellenic Society of Hypertension, Athens, Greece.; National and Kapodistrian University of Athens, Athens, Greece., Gkaliagkousi E; Treasurer, Hellenic Society of Hypertension, Athens, Greece.; Aristotle University of Thessaloniki, Thessaloniki, Greece., Fuchs FD; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.; School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil., Patil M; Chief Program Officer, Hypertension and Nutrition Core Group of India Association for Parenteral and Enteral Nutrition (IAPEN), Maharashtra, India.; Director of IAPEN, Maharashtra, India., Chan AW; President, Hong Kong College of Cardiology, Hong Kong, China., Nemcsik J; Secretary General, Hungarian Society of Hypertension, Budapest, Hungary.; Department of Family Medicine, Semmelweis University, Budapest, Hungary., Tsuyuki RT; President, Hypertension Canada, Toronto, ON, Canada., Narasingan SN; President, Indian Society of Hypertension, Lucknow, India.; Board Member, World Hypertension League, Hong Kong, China., Sarrafzadegan N; President Elect, Iranian Heart Federation, Tehran, Iran.; Professor of Medicine and Cardiology, Director of Isfahan Cardiovascular Research Center, Isfahan, Iran.; WHO Collaborating Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran., Ramos ME; Executive Director, InterAmerican Heart Foundation (IAHF), Dallas, TX, USA., Yeo N; International Council of Cardiovascular Prevention and Rehabilitation (ICCPR), Markham, ON, Canada.; Singapore Heart Foundation, Singapore, Singapore., Rakugi H; President, Japanese Society of Hypertension, Tokyo, Japan., Ramirez AJ; President, Latin American Society of Hypertension, Buenos Aires, Argentina.; Arterial Hypertension and Metabolic Unit, University Hospital, Fundacion Favaloro, Medical Sciences Faculty, University Dr. RG Favaloro, Buenos Aires, Argentina., Álvarez G; President, Latin American Society of Nephrology and Hypertension, Innova, Panama.; Past President of the Central American and Caribbean Association of Nephrology and Hypertension, Santa Domingo, Dominican Republic., Berbari A; President, Lebanese Hypertension League, Beirut, Lebanon., Kim CI; President, Korean Society of Community Nutrition, Seoul, South Korea.; Seoul National University Seoul, Seoul, South Korea., Ihm SH; President, Korean Society of Hypertension, Seoul, South Korea.; Division of Cardiology, The Catholic University of Korea, Seoul, South Korea., Chia YC; Immediate Past President, Malaysian Society of Hypertension, Selangor, Malaysia.; President, Malaysian Society for World Action on Salt, Sugar and Health (MyWASSH), Selangor, Malaysia.; Department of Medical Sciences, School of Medical and Live Sciences, Sunway University, Bandar Sunway, Selangor, Malaysia., Unurjargal T; President, Mongolian Society of Hypertension, Ulaanbaatar, Mongolia.; Department of Cardiology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia., Park HK; General Director, National Institute of Food and Nutrition Service, Seoul, South Korea., Wahab K; Secretary-General, Nigerian Hypertension Society, Ibadan, Nigeria.; Department of Medicine, University of Ilorin, Ilorin, Nigeria., McGuire H; NCD Global Program Leader, PATH, Seattle, WA, USA., Dashdorj NJ; Chief Executive Officer and Co-Founder Onom Foundation, Onom Foundation, Ulaanbaatar, Mongolia., Ishaq M; Secretary General and Founder Trustee, Pakistan Hypertension League, Karachi, Pakistan.; Chair of International Society of Hypertension Regional Advisory Group South, and Central Asia, Colchester, UK.; Karachi Institute of Heart Diseases, Karachi, Pakistan., Ona DID; President, Philippine Society of Hypertension, Pasig City, Philippines.; Department of Medicine, University of the Philippines College of Medicine and St. Luke's Medical Center, Quezon City, Philippines., Mercado-Asis LB; Board Member, World Hypertension League, Hong Kong, China.; Immediate Past President, Philippine Society of Hypertension, Pasig City, Philippines.; Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines., Prejbisz A; President, Polish Society of Hypertension, Gdansk, Poland.; Department of Hypertension, National Institute of Cardiology, Warsaw, Poland., Leenaerts M; Co-Director, Primary Aldosteronism Foundation, Phoenix, AZ, USA., Simão C; Coordinator, Portuguese Society of Paediatric Working Group on Blood Pressure in Children and Adolescents, Lisbon, Portugal., Pinto F; President, Portuguese Society of Hypertension, Lisbon, Portugal., Almustafa BA; Head, Continuous Professional Development, Saudi Hypertension Management Society, Riyadh, Saudi Arabia., Spaak J; President, Swedish Society for Hypertension, Stroke and Vascular Medicine, Stockholm, Sweden.; Associate Professor in Cardiology, Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden., Farsky S; Chairman, Slovak League against Hypertension, Bratislava, Slovakia., Lovic D; Past President, Serbian Society of Hypertension, Nis, Serbia.; Clinic for Internal disease Intermedica Cardiology Department, Hypertensive Centre, Singidunum University, School of Medicine, Belgrade, Serbia., Zhang XH; President, World Hypertension League, Hong Kong, China.

Publikováno v: Journal of human hypertension [J Hum Hypertens] 2023 Jun; Vol. 37 (6), pp. 428-437. Date of Electronic Publication: 2022 May 17.

Hydrochlorothiazide Reduces Cardiac Hypertrophy, Fibrosis and Rho-Kinase Activation in DOCA-Salt Induced Hypertension.

Autor: Mondaca-Ruff D; Laboratory of Molecular Cardiology, Division of Cardiovascular Diseases, School of Medicine, 60709Pontificia Universidad Católica de Chile, Santiago, Chile., Araos P; Laboratory of Molecular Cardiology, Division of Cardiovascular Diseases, School of Medicine, 60709Pontificia Universidad Católica de Chile, Santiago, Chile.; Laboratorio de Fisiopatologia Renal, Instituto de Ciencias Biomédicas, 28041Universidad Autónoma de Chile, Santiago, Chile., Yañez CE; Laboratory of Molecular Cardiology, Division of Cardiovascular Diseases, School of Medicine, 60709Pontificia Universidad Católica de Chile, Santiago, Chile., Novoa UF; Department of Biomedical Sciences, 495640Facultad de Ciencias de la Salud, Universidad de Talca, Talca, Chile., Mora IG; Laboratory of Molecular Cardiology, Division of Cardiovascular Diseases, School of Medicine, 60709Pontificia Universidad Católica de Chile, Santiago, Chile., Ocaranza MP; Laboratory of Molecular Cardiology, Division of Cardiovascular Diseases, School of Medicine, 60709Pontificia Universidad Católica de Chile, Santiago, Chile.; Advanced Center for Chronic Diseases (ACCDiS), 60709Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.; Center for New Drugs for Hypertension (CENDHY), 60709Pontificia Universidad Católica de Chile, Santiago, Chile., Jalil JE; Laboratory of Molecular Cardiology, Division of Cardiovascular Diseases, School of Medicine, 60709Pontificia Universidad Católica de Chile, Santiago, Chile.; Center for New Drugs for Hypertension (CENDHY), 60709Pontificia Universidad Católica de Chile, Santiago, Chile.

Publikováno v: Journal of cardiovascular pharmacology and therapeutics [J Cardiovasc Pharmacol Ther] 2021 Nov; Vol. 26 (6), pp. 724-735. Date of Electronic Publication: 2021 Oct 08.

Reverse Remodeling in Human Heart Failure after Cardiac Resynchronization Therapy Is Associated With Reduced RHO-Kinase Activation.

Autor: Ocaranza MP; Pontificia Universidad Católica de Chile, School of Medicine, Department of Cardiovascular Diseases, Santiago, Chile.; Center for New Drugs for Hypertension (CENDHY), Pontificia Universidad Católica de Chile, Santiago, Chile.; Pontificia Universidad Católica de Chile, School of Medicine, Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile., Jalil JE; Pontificia Universidad Católica de Chile, School of Medicine, Department of Cardiovascular Diseases, Santiago, Chile.; Center for New Drugs for Hypertension (CENDHY), Pontificia Universidad Católica de Chile, Santiago, Chile., Altamirano R; Servicio de Cardiología, Hospital Sótero del Río, Santiago, Chile., de León A; Servicio de Cardiología, Hospital Sótero del Río, Santiago, Chile., Moya J; Pontificia Universidad Católica de Chile, School of Medicine, Department of Cardiovascular Diseases, Santiago, Chile., Lonis A; Pontificia Universidad Católica de Chile, School of Medicine, Department of Cardiovascular Diseases, Santiago, Chile., Gabrielli L; Pontificia Universidad Católica de Chile, School of Medicine, Department of Cardiovascular Diseases, Santiago, Chile., Nab PM; Pontificia Universidad Católica de Chile, School of Medicine, Department of Cardiovascular Diseases, Santiago, Chile., Córdova S; Pontificia Universidad Católica de Chile, School of Medicine, Department of Cardiovascular Diseases, Santiago, Chile., Paredes A; Pontificia Universidad Católica de Chile, School of Medicine, Department of Cardiovascular Diseases, Santiago, Chile., Vergara I; Pontificia Universidad Católica de Chile, School of Medicine, Department of Cardiovascular Diseases, Santiago, Chile., Bittner A; Pontificia Universidad Católica de Chile, School of Medicine, Department of Cardiovascular Diseases, Santiago, Chile., Sabat K; Pontificia Universidad Católica de Chile, School of Medicine, Department of Cardiovascular Diseases, Santiago, Chile., Pastorini K; Servicio de Cardiología, Hospital Sótero del Río, Santiago, Chile.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2021 Apr 23; Vol. 12, pp. 565724. Date of Electronic Publication: 2021 Apr 23 (Print Publication: 2021).

Transplantation of human umbilical cord-derived mesenchymal stem cells improves age-related ovarian functional decline via regulating the local renin–angiotensin system on inflammation and oxidative stress.

Autor: Wei, Lun¹ (AUTHOR), Bo, Le¹ (AUTHOR), Luo, Chao¹ (AUTHOR), Yin, Na² (AUTHOR), Jiang, Wangtao¹ (AUTHOR), Qian, Fei¹ (AUTHOR), Zhou, Anwen¹ (AUTHOR), Lu, Xuanping¹ (AUTHOR), Guo, Huiping³ (AUTHOR) 2640683012@qq.com, Mao, Caiping¹ (AUTHOR) maocaiping@suda.edu.cn

Publikováno v: Stem Cell Research & Therapy. 10/23/2024, Vol. 15 Issue 1, p1-20. 20p.

Hypertension in Cardiovascular and Kidney Disease: Recent Trends – Treating Two Diseases as One.

Autor: De Pascalis, Antonio¹ (AUTHOR) depascalis.a@libero.it, Tomassetti, Alessandro² (AUTHOR), Vetrano, Daniele² (AUTHOR), Tringali, Edoardo² (AUTHOR), Di Lullo, Luca³ (AUTHOR), Napoli, Marcello¹ (AUTHOR), La Manna, Gaetano^2,4 (AUTHOR), Cianciolo, Giuseppe⁴ (AUTHOR)

Publikováno v: CardioRenal Medicine. Oct2024, Vol. 14 Issue 1, p581-587. 7p. 1 Illustration.